Cabotegravir for preventing HIV-1 in adults and young people [ID6255]

Draft guidance

Draft guidance (downloadable version) (PDF 295 KB)

Public committee slides (PDF 882 KB)

Equality impact assessment (downloadable version) (PDF 158 KB)

Committee papers (PDF 9.38 MB)

Final scope (PDF 155 KB)

Final stakeholder list (PDF 175 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 1.09 MB)

Draft matrix post referral (PDF 171 KB)